期刊文献+

壳聚糖关节腔注射对膝骨性关节炎关节功能的影响对比研究 被引量:1

Effect of articular cavity injection of chitosan on the joint function of osteoarthritis patients
下载PDF
导出
摘要 目的观察外源性壳聚糖对膝骨性关节炎关节功能的影响,并与透明质酸钠比较。方法将42例膝骨性关节炎随机分为壳聚糖组20例(26膝)和透明质酸钠组22例(28膝),患膝关节腔注射1%壳聚糖2m l或1%透明质酸钠2m l,1个月内注射3次为1个疗程,1年内4个疗程。测定治疗后1、4、7、12个月关节功能指数,检测关节液中IL-1、IL-6和TNF-α水平改变。结果壳聚糖组治疗、4、7、12个月后的关节功能指数分别为8.6±1.8、7.3±1.7、5.6±1.9,显著好于治疗前,第1、4、7、12个月有效率分别为19.2%、42.3%、50.0%和65.4%,但与透明质酸钠组比较无显著区别。两组患者关节液IL-1、IL-6和TNF-α水平均显著低于治疗前。结论外源性壳聚糖与透明质酸钠均能有效缓解膝骨性关节炎的临床症状。 Objective To investigate the effect of ectogenesis chitosan and hyaluronic acid on the joint function of osteoarthritis patients. Methods Forty-two patients suffered from knee osteoarthritis were divided randomly into chitosan group ( 26 osteoarthritis knees of 20 patients ) and hyaluronic acid group ( 28 knees of 22 patients 1. Two millilitre of one percent chitosan or hyaluronic acid was injected into the articular cavity. Three injections were performed within 1 month every course. Four courses were done within 1 year. Joint function index were observed in 1,4,7,12 months after the first injection,and the content of IL-1, IL-6 and TNF-α of joint fluid were detected. Results In chitosan group, the joint function index were higher than that before treatment. The efficient rate in 1 st,4th,7th, 12th month were 19.2% ,42.3% ,50.0% and 65.4% respectively. There was not any difference between these two groups. The level of IL-1, IL-6 and TNF-α decreased significantly after treatment in both groups.Conclusion Ectogenesis chitosan as well as hyaluronic acid has good effect on osteoarthritis.
出处 《创伤外科杂志》 2006年第5期449-451,共3页 Journal of Traumatic Surgery
关键词 骨性关节炎 壳聚糖 透明质酸钠 白介素1 白介素6 肿瘤坏死因子-α osteoarthritis chitosan hyaluronic acid interleukin 1 interleukin 6 tumor necrosis factor-α
  • 相关文献

参考文献9

二级参考文献16

  • 1尤永平,常津,傅震,刘宁,浦佩玉.超微载体介导反义端粒酶RNA抑制胶质瘤细胞生长的研究[J].中华实验外科杂志,2004,21(11):1296-1297. 被引量:5
  • 2许邵芬 主编.神经生物学:第2版[M].上海:上海医科大学出版社,1999.106-107、252-257.
  • 3金化民 钱辉军 张重.大鼠经皮心脏穿刺取血法[J].中华实验外科杂志,1997,14:167-168.
  • 4Cooper GJ, Underwood MJ, Deverall PB. The lima success story:whither other arterial grafts:are vein grafts obsolete? Br J Clin Pract,1996,50:144-150.
  • 5Angelini GD, Jeremy JY. Towards the treatment of saphenous vein bypass graft failure:a perspective of the Bristol Heart Institute.Biorheology,2002,39:491-499.
  • 6George SJ, Izzat MB, Gadsdon P, et al. Macro-porosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis, 2001,155:329-336.
  • 7Huynh TT, Davies MG, Trovato MJ, et al. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts. J Vasc Surg,1999,29:334-344.
  • 8Madihally SV, Matthew HW. Porous chitosan scaffolds for tissue engineering.Biomaterials,1999,20:1133-1142.
  • 9Meguro T, Nakashima H, Kawada S, et al. Effect of external stenting and systemic hypertension on intimal hyperplasia in rat vein grafts.Neurosurgery, 2000,46:963-969.
  • 10Fung YC,ed. Biomechanical aspects of growth and tissue engineering. In:Fung YC. Biomechanics: motion, flow, stress, and growth. New York: Springer-Verlag, 1990.499-533.

共引文献50

同被引文献34

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部